Water Extract of Ling Zhi (Ganoderma lucidum (Leysser) Karsten) Increases the Percentage of Relative CD8+ T Lymphocyte Cell in Rat Induced by Doxorubicin
Abstract
Cancer therapy using chemotherapeutic agents associated with many adversed side effects, including immunosupressant. The use of immunostimulator together with chemotherapeutic agent (co-chemotherapy) can be the alternative method to solve that problem. Ganoderma lucidum (Ling Zhi) has been reported to have immunostimulatory activity. The aim of this research was to evaluate the immunostimulatory activity of water extract of G. Zucidum by determining the relative CD8+ T lymphocyte cell percentage in rats induced by doxorubicin. Extraction of plant material was carried out by infusion method. Sprague Dawley female rats were divided into six groups, they were doxorubicin as control, commercial product as comparing control, 100 mg/kgBW and 450 mg/kgBW extract treatment, extract control, and without treatment control. Relative CD8+ T lymphocyte cell percentages of blood samples were obtained by flow cytometry by using Multiset program. The data were analyzed statistically using paired sample t test and one way ANOVA continued by Post Hoc test. The result showed that the water extract of G. lucidum increased the relative CD8+ T lymphocyte cell percentage in rats induced by doxorubicin. The water extract of G. lucidum is promising to be developed as co-chemotherapy immunostimulatory agent.
References
2. Patel D, Shukla S, Gupta. Apigenin and cancer chemoprevention: progress, potensial, promise (Review). Int J Oncol. 2007. 30:233-45.
3. Zhang X, Li WG, Wu YJ, Gao MT. Amelioration of doxorubicin induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumor bearing mice. J Pharm Pharmacol. 2005. 57(8):1043-51.
4. Sliva D. Ganoderma lucidum in cancer research. Leukemia Research. 2006. 30:767-8.
5. Lin Z. Cellular and molecular mechanism of immunomodulation by Ganoderma lucidum. J Pharmacol Sci. 2005. 992144-53.
6. Pillai TG, Salvi VP, Maurya DK, Nair CKK, J anardhanan. Prevention of radiation-induced damages by aqueous extract of Ganoderma lucidum occurring in southern parts of India. Current Science. 2006. 91(3):341-4.
7. Anonim. MlMS Indonesia Petunjuk Konsultasi. Edisi 7. Jakarta: PT. Info Master; 2008. 252.
8. Ikawati I, Fitria M, Fauzi IG. Ekstrak etanolik daun awar-awar (Ficus septica Burm. F.) sebagai imunomodulator pada tikus galur Sprague Dawley yang dipej ani doxorubicin [laporan penelitian PKM-P]. Yogyakarta: Fakultas Farmasi Universitas Gadjah Mada; 2009.
9. Anonim. Ganoderma lucidum’s anti cancer properties investigated; 2003. diambil dari http://www. thehealthierlife.co.uk. diakses 29 November, 2010.
10. Liang JB, Chen X, Wang J, Cheng B. HPCE determination of monosaccharide composition of Ganoderma lucidum polysaccharides [abstract]. Chin J Pharm Anal. 2008. diambil dari http://en.cnki.com. cn/Article_en/CJFDTOTAL-YWFX2008 l 1022.htm. diakses 29 November, 2010.
11. Anonim. Determination of reducing sugar by LuffSchoorl’s methods. 2002. diambil dari http://WWW. starchdk/isi methods/28luffhtm. diakses 29 November, 2010.
12. Anonim. CD8. 2009. diambil dari www.wikipedia.com. diakses 29 November, 2010.
13. Anonim, T Cell. 2009. diakses dari www.wikipedia.com. diakses 29 November, 2010.
14. Gabriel JA. The biology of cancer. 2nd ed. England: John Wiley & Sons LTD; 2007.
15. Lin ZB, Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible nechanism [review]. Acta Pharmacol Sin. 2004. 35(11):1387-95.
16. Wang YY, Khoo KH, Chen CC, Wong CH, Lin CH, Ihen HS, et al. Immune-modulating antitumor activities f Ganoderma lucidum (Reishi) polysaccharides. US atent 7135183. 2006.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.